Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003459960 | SCV004193378 | likely pathogenic | Glycogen storage disease type III | 2024-02-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003459960 | SCV004279240 | pathogenic | Glycogen storage disease type III | 2023-01-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg784Lysfs*6) in the AGL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGL are known to be pathogenic (PMID: 19299494). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with AGL-related conditions. For these reasons, this variant has been classified as Pathogenic. |